Form 4: Dexcom Executive Sells Shares to Cover Tax Obligations

Dexcom's Executive Vice President and Chief HR Officer, Sadie Stern, sold 424 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Sadie Stern, Executive Vice President and Chief HR Officer at Dexcom Inc., sold 424 shares of common stock on December 16, 2024.
• The sale was executed at a price of $76.87 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• The sale was not a discretionary trade but rather a mandatory action under Dexcom's equity incentive plans.
• Following the transaction, Ms. Stern beneficially owns 70,768 shares of Dexcom common stock, which includes 43,283 unvested restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither positive nor negative for the company's performance, but it is a normal part of operations.

Industry Context

This is a routine transaction for executives who receive equity compensation. It is common for companies to require 'sell to cover' transactions to manage tax obligations.

Comparison to Industry Standards

• Many companies use 'sell to cover' mechanisms for executives' equity compensation.
• The number of shares sold is relatively small compared to the total shares owned by the executive, which is typical for these types of transactions.
• The vesting schedules for the RSUs are standard for executive compensation packages.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• The sale does not indicate any change in the executive's confidence in the company.

Key Dates

Keywords

Dexcom, Executive Stock Sale, Form 4, Insider Trading, Restricted Stock Units, Tax Withholding, Equity Incentive Plans, Sadie Stern